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The gene product of the minor lymphocyte stimulatory locus Mls-1a is respon-
sible for the activation of a large proportion (up to 20%) of T lymphocytes in un-
primed mice (1, 2). Recent studies indicate that at least three independent TCR
Vs domains (V06, V08.1, and V09) confer preferential reactivity of T cells to Mls-
la determinants, and that mature T cells bearing these VS are clonally deleted in
Mls-la strains (3-5). Thus, this V0 preference probably accounts for the high fre-
quency of Mls-1 a-reactive T cells.
In analogy with responses of CD4+ T cells to conventional peptide antigens, T
cell reactivity to Mls-l a requires the coexpression of MHC class II molecules (par-
ticularly I-E) on the stimulating cells and can be blocked by mAbs directed against
MHC class II. Furthermore, essentially all published T cell clones and hybridomas
exhibitinganti-Mls-la reactivity are CD4+, and responsiveness of polyclonal T cell
populations to Mls-1a can be completely inhibited by anti-CD4 mAbs. These
findings have been collectively interpreted as demonstrating that Mls-1a reactivity
is restricted to the CD4+ T cell subset (6).
In this work, we have reinvestigated the response of CD8+ T cells to Mls-1a de-
terminants. Taking advantage of the availability of Mls-1 congenic mouse strains
(7), we find that CD8+ cells using V06+ and Vsa.l + TCRs are dramatically enriched
after in vitro or (to a lesser extent) in vivo stimulation by Mls-1a . The parallel se-
lection of TCR V0 domains in both CD4+ and CD8+ subsets by Mls-1a is reminis-
cent of T cell responses to other MHC class II-dependent "superantigens" such as
bacterial enterotoxins.
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Materials and Methods
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Mice.
￿
Congenic BALB/c (H-2d, Mls-1b) and BALB.D2 .MlSa (H-2d, Mls-la) mice were
maintained from breeding pairs kindly provided by Dr. H. Festenstein (7). DBA/2 (H-2
d,
Mls-la), DBA/1 (H-2q, Mls-la), and CBA/J (H-2k, Mls-la) mice were obtained from Harlan-
Olac U.K., Bicester, UK. F, hybrids between BALB/c and either CBA/Ca (H-2k, Mls-1b)
or B10.G (H-29, Mls-1b) mice were bred locally.
MixedLeukocyte Cultures.
￿
Nylon wool-purified responder splenic T cells (1.5 x 106) were
cultured with irradiated (1,000 rad) antiThy-1 plus complement-depleted splenic stimulator
cells (4.5 x 106) in 2 ml DME supplemented with 5% FCS and 5 x 10-5 M 2-ME. In some
experiments, responder populations were depleted of CD4* or CD8' cells by further treat-
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ment with rat IgM mAbs RL172.4 (anti-CD4) or 3.168.1 (anti-CD8)plus rabbit complement
before culture. In the case of CD4 depletion, the resulting CD8' responder cells were fur-
ther supplemented with supernatant of PMA-stimulated EL4-6.1 cells (corresponding to 30
U/ml IL-2).
Blast Purification.
￿
After 3 d in culture, respondingT cell blasts were isolated on a Percoll
density gradient (8) and resuspended (2 x 105 viable cells/ml) in fresh medium supplemented
with human rIL-2 (60 ng/ml). After a further 2-3 d (during which time cell density increased
7-10-fold), cells were recovered and analyzed for VS expression.
In Vivo Transfers.
￿
BALB/c mice were irradiated (850 rad from a 131CS source). After 20
h, mixtures of purified T cells and (unirradiated) B cells were injected intravenously into
groups oftwo mice. Spleens were recovered and pooled 7-9 d later, and T cells were repurified
on nylon wool columns before analysis of Vs expression. Survival was 100% in all ex-
periments.
Flow Microfluorometry.
￿
All procedures and reagents have been described (3). Cells were
initially stained with TCR Vg-specific mAbs 44-22-1 (anti`V06), KJ16 (antiV,68.1/8.2), and
F23.2 (antiVs8.2) followed by appropriate fluoresceinated anti-Ig. Additional staining was
with phycoerythrin-conjugated GK-1.5 (anti-CD4)or biotinylated 53-6.7 (anti-CD8; revealed
with avidin-PE).
Fluorescence histograms for Vs staining were gated independently on CD4' or CD8' cells
(see Fig. 1 for example). The percentage of positive cells in each subset expressing each VS
was calculated directly from the gated histograms (except for Vp8.1, which was determined
by subtraction of F23 .2 staining from KJ16 staining).
Results and Discussion
To assess the possibility that CD8+ T cells may respond to Mls-la-encoded de-
terminants, we took advantage ofthe availability ofthe congenic mousestrains BALB/c
and BALB.D2.MlSa (7). Purified T lymphocytes from BALB/c (Mls-1b) mice were
stimulated with lightly irradiated Mls-la congenic B cells (T-depleted spleen), and
the resulting T cell blasts were isolated and reculturedin rIL-2. This expanded popu-
lation was then double stained with mAbs directed against TCR Vs domains and
either CD4 or CD8. As expected from previous studies (3, 4), the CD4+ blast subset
was highly enriched in cells expressing VS6 and V08.t after Mls-la stimulation (Fig.
1, Table I). Surprisingly, similar analysis of the CD8+ subset revealed almost iden-
tical proportions of cells expressing each of these VS elements (Fig. 1, Table I). In
each case, V06' cells were enriched five- to sixfold and V08.1 cells two- to fourfold
as compared with the control (unstimulated) subset. This pattern of VS expression
among CD8' cells was dependent upon Mls-la stimulation since control stimula-
tion (with syngeneic Mls-1 b splenic B cells) resulted in proportions of V06' and
V08.1' cells similar to those found in the freshly isolated population (Table I). Fur-
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FIGURE 1. TCR Vg expression by
CD4' and CD8' T cell subsets after Mls-
la stimulation in vitro. BALB/c anti-Mls-
la T cell blasts were isolated and double
stained with antiTCR VS mAbs together
with either anti-CD4 or anti-CD8 mAbs.
Histograms shown are gated on either
CD4' or CD8' cells.MacDONALD ET AL. BRIEF DEFINITIVE REPORT
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TABLE I
Expression of TCR V 'B Domains by CD4+ and CD8' T Cell Blasts
Responding to Mls-1° Determinants In Vitro
Nylon wool-purified splenic responder T cells (1 .5 x 106) were mixed with irradiated (1,000 rad) T
cell-depleted splenic stimulator cells (4.5 x 106). After 3 d, responding T blasts were isolated on a Percoll
gradient and recultured for 2-3 d in rIL-2 (60 ng/ml). Recovered cells were double stained with mAbs
directed against the indicated TCR Vp domains and either CD4 or CD8 (see Fig. 1).
' Responding T cells were CD4 depleted (CD8') or CD8 depleted (CD4*) before culture. For subsequent
stimulation ofCD8' T cells, IL-2 (30 U/ml in the form of EL4 supernatant) was added from the outset.
thermore, enrichment ofMls-1a-specific CD8' VS6' cells did not require the simul-
taneous activation ofCD4' cells as shown by CD4 depletion experiments (Table I).
The response of CD4' Tcell clones and hybridomas to Mls-la determinants de-
pends upon coexpression ofMHC class II molecules by the stimulating cells, with
a marked preference for H-2k and H-2d haplotypes and essentially no response to
H-2q (2). As shown in Table I, CD8 VR6+ cells from appropriate (MIs-1 6)Fl mice
responded preferentially to Mls-la in the context ofH-2d (BALB.D2.MlsaorDBA/
2) or H-2k (CBA/J) stimulator cells, but no such selection was seen with H-2q
(DBA/1). Predictably, the response ofCD4+ cells followed essentially the same pat-
tern (Table I), although a small but significant (twofold) enrichment in Vf6+ cells
wasalsoseen with DBA/1 stimulator cells. Thislatter result may reflect aweakstim-
ulation of CD4+ cells by Mls-la in the context of H-2q; alternatively, Mls-1a may
be reprocessed and presented by residual (I-E+)F1 cells, as shown previously for a
T cell clone (9). In either event, the fact that clonal responses ofboth CD4+ and
CD8+ T cells to Mls-la were dependent upon the same MHC alleles raises the pos-
sibility that class II molecules are also involved in Mls-1a-specific stimulation ofthe
CD8' subset. More direct experiments will be required to confirm this hypothesis.
Since reactivity ofCD8' Tcells to Mls-la was somewhat unexpected, we also in-
vestigated this response in an adoptive transfer system in vivo. Preliminary experi-
ments established that reproducible responses to MIs-1a in irradiated hosts required
coinjection of both Mls-16 T cells and Mls-la B cells, presumably because B cells
Mixed leukocyte culture
Responder Stimulator CD4* CD8'
Proportion of
VB6 V08.1
CD4*
V#8.2
Proportion of
Vd6 V08.1
CD8'
V/38.2
BALB/c BALB/c 68 16 12.7 7.0 15.0 10.4 8 .7 20.0
BALB/c BALB .D2.Mls' 75 15 55.5 27.3 4.2 64.4 19.5 7.0
BALB/c (CD8*)` BALB.D2.Mlsa <1 64 - - - 64.0 ND ND
CBA/Ca x BALB/c None 53 33 11 .7 4.8 14.8 12.9 8.1 16.4
CBA/Ca x BALB/c BALB.D2.Ml3a 76 15 69.7 22 .6 2.2 62.7 15 .9 2.6
CBA/Ca x BALB/c CBA/J 76 16 67.8 26.2 3.1 56.3 28.4 2.4
CBA/Ca x BALB/c (CD4*)' BALB.D2.Mlsa 98 <1 72.5 18.0 3 .4 - - -
CBA/Ca x BALB/c (CD8*)' BALB.D2 .Mlsa <1 80 - - - 57.3 14.7 6.2
CBA/Ca x BALB/c (CD8*)' BALB/c <1 49 - - - 9.0 12.6 19 .0
B10.G x BALB/c None 46 29 10.4 1 .5 21 .4 12 .1 9.4 14.3
B10.G x BALB/c (CD4*)' DBA/2 95 ND 66.1 31 .1 3 .5 - - -
BIO.G x BALB/c (CD4*)' DBA/1 76 ND 22 .2 8.6 22.4 - - -
BIO,G x BALB/c (CD8*)' DBA/2 ND 90 - - - 66.9 12 .4 2.6
B10.G x BALB/c (CD8*)" DBA/l ND 65 - - - 10.0 8.6 14.61384
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responsible for Mls-1a stimulation are highly radiosensitive (10). Using this system,
we determined the Vs composition ofsplenic T cell populations derived from ir-
radiated BALB/c mice givenvaryingdoses ofsyngeneic (BALB/c) T cells and acon-
stant number (3-4 x 10) ofcongenic BALB.Mlsa B cells. The result ofthis anal-
ysis for CD4' T cells (Table II) demonstrated a dramatic increase in V06 and V08.t
expression over a wide (-30-fold) range ofdonor T cell doses. Thus, Vp6' cells ac-
counted for 52% ofthe total CD4' population (similarto the in vitro data), whereas
Vpa.t' cells accounted for 10-12%. Results obtained in this system forCD8' T cells
were considerably morevariable (Table II); in fact, significantnumbers ofthese cells
were notobtained inallexperiments, even atthe highestdonorT celldoses. Neverthe-
less, when CD8' cells were present, Vp6' and Vsa.l' cells were significantly enriched
(about twofold). It should be noted that alterations in V,8 expression in both CD4'
and CD8' subsets were again strictly dependent upon the presence ofMls-la B cells,
since animals reconstituted with a mixture of syngeneic (BALB/c) T and B cells
did not differ from unmanipulated controls (Table II).
The apparently reduced efficiency ofMls-la-specific stimulation ofCD8' cells in
the in vivo model system (as compared with mixedleukocyte cultures) requires fur-
ther analysis. In this regard, in vitro stimulation ofCD8' Mls-la-specific cells may
be favored by the presence of IL-2, since we were unable to detect preferential ex-
pansion ofVs6' or V08,I ' cells using CD4-depleted responder populations unless
exogenous IL-2 was added (data not shown).
The data presented here do not support the generally accepted dogma that only
CD4' T cells respond to Mls-la determinants (6), nor are they consistent with re-
cent evidence that CD$ expression inhibits responses to MHC class II-restricted
TABLE II
Selective TCR V,B Expression on CD4+ and CD8' Cells
Responding to Mls-1° Determinants In Vivo
Irradiated BALB/c mice (two mice per group) were reconstituted 20 hlater with varying numbers ofresponder
BALB/c splenic T cells and a constant number (3.5 x 107) of BALB .D2.Mls' (or control BALB/c) T cell-
depleted splenic stimulator cells, After 7-9 d, CD4' and CD8' splenic T cells from reconstituted mice
were analyzed for Vp expression as in Fig. 1 . Control values for normal BALB/c mice are given in Table I
(first line).
' Insufficient CD8' cells for analysis (<I%).
Cells transferred
Responder Stimulator CD4' CD8'
Proportion of
V06 VS8.1
CD4'
V08.2
Proportion of
V06 V88.1
CD8'
Vp8.2
0 /0
5 x 106 BALB/c BALB/c 60 12 13.5 8.9 15,6 11 .8 5.7 22.7
1 .5 x 107 BALB/c BALB.132 .Mls' 69 14 52.3 10.2 7.8 25 .3 11 .0 19.6
52.6 11 .1 8.1 21 .4 7.8 25.9
52.5 10.8 7.1 -" - -
5 x 106 BALB/c BALB.D2 .Mls' 51 8 53.3 11 .3 8 .4 22.9 10.0 19.3
52.5 13 .6 6 .2 - - -
1 .5 x 106 BALB/c BALB.132.Mls' 54 4 52.8 10.8 7 .6 22.8 13.9 17.3
5 x 105 BALB/c BALB.D2.Mls' 38 <1 48.3 10 .7 8 .1 - - -
5 x 104 BALB/c BALB.D2.Mls' 40 <1 19.6 3.7 14.5 - - -
None BALB.D2.Mls' 24 <1 6.9 3.9 16 .1 - - -MacDONALD ET AL.
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antigens (as well as Mls-1 a) in transfected Tcell hybrids (11). Nevertheless, our re-
sults arecompatible with an isolated report inwhich proliferation ofan MHC class
I-restricted CD8' clone specific for influenzaviruswas found to correlate with Mls-
la expression in the absence ofnominal antigen (12). Moreover, increased V06 and
V#8.1 usage has recently been observed amongCD8' T cells stimulated with MHC-
incompatible T cell blasts derived from Mls-1 a strains (13). Although the latter
system is more complex than ours (involving both MHC and minorantigen differ-
ences in addition to Mls-1a), both studies point to a generalized V,o-specific clonal
response of CD8' T cells to Mls-1a determinants.
Finally, in a broader context, the parallel V,6 usage among CD4' and CD8' T
cells responding to Mls-la may reflect a more general property ofthe class ofmito-
genic substances currently referred to as superantigens (14). In this regard, the
Staphylococcal enterotoxins (the onlysuperantigensyet defined inmolecularterms)
also elicit MHC class II-dependent responses from both CD4+ and CD8' T cells
(15), and recent data indicate that VS usage is similar in both subsets (16). Further-
more, I-E-dependent responses ofV#11 ' and V017a' T cells (which involveundefined
ligands functionally analogous to superantigens) can be mediated by CD8' cells in
certain instances (17, 18). Since TCRs on all CD8' mature Tcells are presumably
selected forMHC classI( t peptide?) recognitionduring thymic development(19),
the preferential use of certain V0 domains by these cells in MHC class II-depen-
dent responses to superantigens is most easily reconciled with models involving di-
rect TCRsuperantigen interaction. Onepossibility mightbe that superantigens first
bind to MHC class II molecules in ordertopresent determinant(s) that can interact
effectively with the appropriate TCR V,0 domains.
Summary
T cell responses to the product of the minor lymphocyte stimulatory locus Mls-
la involve the selective use ofTCR VS domains (especially V#6 and V#8.1) and are
generally considered to be restricted to the CD4* mature subset. We show here that
CD8' (presumably MHC class I-restricted) T cells bearing V06 or V08.1 also re-
spond preferentially to Mls-la determinants either in vitro (in mixed leukocyte cul-
tures) or in vivo (in an adoptive transfer system). In vitro responses of both CD4+
V06' and CD8+ Vs6' cells to Mls-la were dependent upon the MHC haplotype of
the stimulator cells, with I-E' (H-2d or H-2k) alleles beingmuch more stimulatory
than I-E" (H-29). These data strengthen the analogy between Mls gene products
andotherMHCclass II-dependent superantigenssuchasthebacterialeriterotoxins.
We thank P Zaech and C. Knabenhans for flow cytometry and A. Zoppi for preparation
of the manuscript.
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